- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Nikki Reeves
Events 22 results
Speaking Engagement
April 25, 2022
Nikki Reeves to Speak at Pharmaceutical Compliance Congress
Webinar
January 25, 2022
2021 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned From FDA Enforcement Letters and Other Key Developments
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
November 2, 2021
Craig Carpenito, Dixie Johnson, Nikki Reeves, Seth Lundy to Speak at Virtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Webinar
January 27, 2021
Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2020 FDA Enforcement Letters and Other Key Developments
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Speaking Engagement
October 19, 2020
Nikki Reeves, Gillian Russell to Speak at Seton Hall Law School’s U.S. Healthcare Compliance Certificate Program
Speaking Engagement
April 30, 2020
Nikki Reeves to Speak on Pharma and Medical Device Ethics and Compliance Webinar
Webinar
January 29, 2020
2019 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2019 FDA Enforcement Letters and Other Key Developments
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Speaking Engagement
November 6, 2019
John Richter, Richard Walker, Nikki Reeves to Speak at 20th Annual Pharmaceutical and Medical Device Compliance Congress